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results: We assessed the incidence of intra-atdal clot in AF patients who received Cou- 
madin for >3 weeks but had sub-therapeutic INR on >_2 measurements in the last three 
weeks before the scheduled cardioversion. From 1/1996 to 6/2001, 192 consecutive 
patients (105 men, 77 women, mean age 67±12 years) with sub-therapeutic INR under- 
went transesophageal echocardiography (TEE). An intra-atdal clot was detected in 18 
(9.9%) patients. None of the 21 patients with left atrial diameter <_40 mm had intra-atrial 
clot, yielding an atrial-clot incidence of 11.2% in AF patients with left atrial diameter >40 
ram. The left atrial diameter was significantly larger in patients with intra-atrial clot versus 
those without intra-atrial clot (50.2i-6.1 versus 46.4+8.0 ram, p<0.05). There was no sig- 
nificant difference in left ventricular ejection fraction compadng patients with and without 
intra-atrial clot (51_+6% versus 52_+12%, p=0.91). A single therapeutic INR one week 
before TEE did not predict absence of intra-atrial clot (intra-atdal clot was found in 13/90 
patients with INR >2.0 versus in 5/92 patients with INR<2.0). The scheduled card/over- 
s/on was postponed in all patients with intra-atrial clot. 
Conclusion: The incidence of intra-atrial clot in patients on conventional ant/coagulation 
but with sub-therapeutic INR is close to that of the un-anticoagulated patients, suggest- 
ing the need for TEE before AF card/overs/on unless the patient has a normal left atrial 
diameter. 
1163-67 Maintenance of Sinus Rhythm After Card/overs/on Is 
Dependent on Immediate Improvement of Left 
Ventricular Systolic and Diastolic Function 
Kazumasa Harada, Makoto Sonoda, Hiroshi Nishimura, Katsu Takenaka, Ryozo Nagai, 
Toshiyuki Takahashi, University of Tokyo, Tokyo, Japan. 
Background: An increase in ejection fraction after cardioversion from atrial fibrillation 
(AF) has been attributed to improvement of atrial mechanical function, but patients main- 
taining sinus rhythm and those with ultimate reversion to AF may have different mecha- 
nisms. Methods: To test whether immediate improvement in left ventricular (LV) systolic 
function after cardioversion is the result of return of atrial function or the result of 
improvement in LV diastolic function, we measured LV volumes, transmitral flow veloci- 
ties, and pulmonary venous flow velocities before and 24 hours after elective cardiover- 
sion in 17 patients. ALOGIQ 500 (GE Yokogawa Medical System Ltd) was used. All 
patients had duration of AF more than 1 month, and received bepridil (150 mg/day) 
throughout the study. Results: Ten patients maintained sinus rhythm more than I month 
after cardioversion (SR) and seven showed the reversion to AF within 1 month (ReAF). 
Immediately following cardioversion, ejection fraction and LV stroke volume (SV) 
increased significantly only in the SR group (118+21%*, 148-+16%*, *p<0.05 vs. base- 
line), but not in the ReAF group (99-J:13%, 103+9%). In contrast, relative increases in 
cycle length were comparable. Transmitral peak A-wave velocity at 24 hours did not differ 
significantly between the groups (SR, 36.6-+13.1cm/s; ReAF, 32.2+11.3cm/s), nor corre- 
lated with the improvement of SV after cardioversion (r=0.20). The increases in SV of the 
SR group were attributable to those in LV end-diastolic volume (SR, 123+~2%#; ReAF, 
103±16%, #p<0.05 vs. ReAF), but not the changes in LV end-systolic volume (SR, 
102+31%; ReAF, 107-+27%). Moreover, the ratio of S-wave/D-wave of the pulmonary 
venous flow velocities at 24 hours was comparable (SR, 0.66i-0.26; ReAF, 0.741~.44). 
Conclusion: Maintenance of sinus rhythm after cardioversion is suggested to be depen- 
dent on the immediate improvement of LV diastolic, as well as systolic function. 
1163-68 The Exact Time Course of Recovery of  Left  Atrial 
Appendage Function Following Reversion of Chronic 
Atrial Flutter to Sinus Rhythm 
Mitsuaki Takami, Makoto Suzuki, Yoshihisa Enjoji, Takuya Inoue, Takanori tkeda, Kaoru 
Sugi, Tetsu Yamaguchi, Third Department of Internal Medicine Toho University Ohashi 
Hospital, Tokyo, Japan. 
Background: Left atrial appendage (LAA) stunning is thought to be associated with 
thrombus formation and embolic stroke. This phenomenon is observed not only following 
cardioversion of atrial fibrillation (AF) but also that of atrial flutter (AFL). Therefore, throm- 
boprophylaxis for AFL requires ant/coagulation prior to, and following, card/overs/on, but 
little information has been obtained how long ant/coagulation is required following card/o- 
version of chronic AFL 
Methods: Twelve patients with chronic AFL (duration: 30 _+ 41 months, range: 4-134) 
undergoing curative radiofreduency ablation (RFA) were enrolled. No patient had been 
documented AF before the study. LAA velocities, LAA fractional area change and spon- 
taneous echo contrast (SEC) were assessed using a transesophageal echocardiography 
before and within 24 hours, 1 week and 2 weeks following RFA. 
Results: Within 24 hours following RFA, LAA velocities and LAA fractional area change 
decreased significantly. LAA velocities and LAA fractional area change increased mark- 
edly through 2 weeks following RFA. LAA velocity was over 32 cm/s in all patients at 2 
weeks following RFA. Six (50%) of 12 patients developed SEC within 24 hours following 
RFA. SEC had resolved in all patients at 2 weeks following RFA. (see table) 
Conclusion: All indices of thromboembolic risk improved within 2 weeks following rever- 
sion of chronic AFL to sinus rhythm. After card/overs/on of chronic AFL, patients may 
require ant/coagulation up to 2 weeks. 
before RFA within24hrs 1week 2weeks 
LAA velocities (cm/s) 42±8 19±7" 40± 161" 54± 14# 
range 31-56 8-31 14-67 32-86 
LAA fractional area change (%) 46±7 22±9* 39±101" 48±6§ 
Documented SEC (n) 0 6 (50%) 2 (17%) 0 
*p < 0.01 vs before RFA, I"P < 0.01 vs within24hrs, #p < 0.01 vs 1week 
§p < 0.05 vs 1week 
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1164-59 Stress Echo in Chest Pain Unit: The SPEED (Stress 
Pharmacologic Echocardlography in Emergency 
Department) Trial 
Gigliola Bedetti, Emilio Pasanisi. Giancarlo Tintori, Lucas Fonseca, Simone Tresoldi, 
Calogero Minneci, Andres Orlandini, Bruno Ghelarducci, Raffaele Bugiardini, Eugenio 
Picano, CNR, Institute of Clinical Physiology, Pisa, Italy, Cardiology Dept., Imola 
Hospital, Imola, Italy, 
Background: emergency room (ER) evaluation of patients with acute chest pain and non 
diagnostic electrocardiography (ECG) remains a frequent and difficult problem. Aim: to 
assess the safety and prognostic implication of stress echocardiography in the ER chest 
pain unit (CPU). Methods: 482 patients (287 males/age 62±11 years) with acute chest 
pain and negative serial cardiac markers, and ECG recordings and normal/unchanged 
resting left ventricular function, underwent stress echo (dipyddamole n= 451, dobutamine 
n=11, exercise n=20) within 12-36 hours after admission. Six echo labs quality-controlled 
for stress echo reading entered the study. Follow-up was obtained in all patients after 8 ± 
5 months. Results: no significant adverse events were observed during the tests. Feasi- 
bility was 99%. Stress echocardiography was negative in 448 and positive in 34 patients. 
Patients with negative stress echocardiography were discharged with no or unchanged 
anti-ischemic medication. Patients with positive stress echo were admitted to coronary 
care unit. In 30 of them coronary angiography was performed and showed significant cor- 
onary artery disease in 28: one vessel in 11, two vessel in 4, three vessel disease in 11 
and left main disease in 2 patients. There were 30 events in the follow-up: four (two acute 
myocardial infarction and two unstable angina requiring revascularization) in the 448 pts 
with negative and 26 (25 unstable angina requiring revasculadzation and one acute myo- 
cardial infarction) in the 34 patients with positive stress echo (0.89% vs 76.5%, p<.O01). 
The negative predictive value Of stress echocardiography for subsequent events was > 
99%. Conclusion: stress echocardiography is feasible, safe and effective tool for early 
stratification of patients with acute chest pain and non-diagnostic ECG, cardiac markers 
and resting echo admitted to the ER. 
1164-60 Noninvasive Assessment of Left Anterior Descending 
Artery Coronary Flow Reserve by Transthoraclc 
Echocardiography: Feasibility and Results 
Fausto Rigo, Walter Curtaia, C~audio Zanefla, Pietro Nicolin, Paolo Della Valentina, 
Lorenza Pratali, Attila Palinkas, Alberto Raviele, Euaenio Picano, CNR, Institute of 
Clinical Physiology, Pica, Italy, Division of Cardiology, Mestre Hospital, Mestre, Ital Z 
Background: Coronary flow reserve (CFR) is a key physiological parameter which can 
be evaluated noninvasively by transthoracic echocardiography (]-I'E) during vasodilator 
stress. Aim: To assess the feasibility and physiologic meaning of TTE assessment of 
CFR. Methods: Starting June 1, 2000 to August 1, 2001, 239 consecutive patients (12 
males; age=67±19 years) were referred for stress echocardiography. In all, TTE ($12 
probe, HP 5500, Agilent technology) evaluation of distal left anterior descending (LAD) 
coronary artery was attempted at baseline and following dipyridamole (0.84 mg/kg). 
Wherever color-coded LAD blood flow from the baseline could not be obtained, contrast 
enhancement with Levovist (Schering AG) was used. Peak diastolic coronary flow veloc- 
ity of LAD was recorded by pulsed Doppler under the guidance of Color Doppler flow 
mapping. CFR was calculated as the ratio of dipyddamole / rest peak diastolic flow veloc- 
ity. Results: The overall feasibility was 93% in the first 100 patients and rose to 98% in 
the latter 139 (p<.05). The need for contrast injection was 38% in the first 100 and 18% in 
the latter 139 patients (p<.01). In patients with complete clinical and angiographic char- 
acterization, CFR values were 3.2-Z0.2 in control group (n=14); 2.4 + 0.4 in Syndrome X 
(n= 43); 2.5!-0.3 in patients evaluated early after CABG with left internal mammary artery 
on LAD (n=28); 2.3 + 0.4 in patients evaluated early after PTCA (n=45); 1.4£<).2 in cdtical 
(>70%) native LAD stenosis (n=24); 1.85i-O.22 in dilated cardiomyopathy (n=8); 2.01t-0.2 
in hypertrophic cardiomyopathy (n=9); 1.8±0.3 in aortic stenosis (n= 7). Conclusion: 
Noninvasive evaluation of CFR by TTE is highly feasible in the echo lab during vasodila- 
tor stress echo. After a limited learning curve, contrast injection is rarely needed - further 
simplifying and reducing the cost of examination. Physiologically congruent results of 
potential clinical value can be obtained during vasodilator stress echo in different patho- 
physiological conditions, ranging from coronary artery disease to cardiomyopathy. 
1164-61 Color Kinetics During Contrast-Enhanced Dobutamine 
Stress Echocardiography: Its Feasibility and 
Applicability 
Masaaki Takeuchi. Hidetoshi Yoshitani, Chinami Miyazaki, Shinichiro Otani, Kazuo 
Sakamoto, Junichi yoshikawa, Junichi Yoshikawa, Tane General Hospital, Osaka, Japan, 
Graduate School of Medicine Osaka City University, Osaka, Japan. 
Background: Accurate interpretation of dobutamine stress echocardiography (DSE) 
needs expertise. Color kinetics (CK) allows objective assessment of wall motion (WM), 
and its feasibility and accuracy would enhance under harmonic imaging with contrast 
agents. Methods: To explore its utility, we had performed CK in 36 unselected patients 
during contrast-enhanced DSE. After bolus injection of Levovist, we acquired CK image 
in apical 4 and 2 chamber view at baseline and peak stress using ultraharmonic mode 
(SONOS5500, $3 probe). Quad screen format with second harmonic imaging after 
another injection of Levovist was also obtained as a gold standard. Regional wall motion 
